More importantly, there was a significant upregulation of MUC16 expression in the non-responder breast cancer patients compared to the chemotherapy responders, with an AUC (sensitivity and specificity) of 0.573 (P = 2.6e−03) (Fig. 1E–F). Here, MUC16 is linked to breast cancer.